Aimo Kannt, PhD is Head of Drug Discovery and Preclinical Research at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Professor of Translational Drug Research at Goethe University Frankfurt. After his PhD and postdoctoral training at the Max Planck Institute of Biophysics and prior to joining Fraunhofer, he worked for 20 years in different roles at Sanofi and its predecessor companies, in the areas of assay development and high-throughput screening, cardiovascular and diabetes drug discovery. 

“Cardiac disease is a major killer. Scalable human 3D heart tissue models offer unique opportunities to explore pathways relevant to cardiac pathophysiology and discover and develop new treatment options that are urgently needed.”